FATE THERAPEUTICS INC
FATENASDAQ🏆 #3458 by market capEarnings Oct 29US Equity
$2.40▲ $0.02 (+0.63%)
LiveTrack FATE
Get earnings, price moves & breaking news on Telegram
24h▲ 0.6%
7d▼ 1.4%
14d▼ 1.4%
30d▼ 0.2%
ytd▲ 143.2%
1y▲ 90.1%
🏦Market Cap
$279M
Small Cap
📈Revenue Growth (YoY)
-51.2%
Declining
📊Gross Margin
-343.0%
Thin
💵FCF Margin
-1627.8%
Thin
⚖️P/S Ratio
43.2x
Expensive
Otter Score
72
Fair
FATE THERAPEUTICS INC
FATEAnalyst Ratings
Price
$2.40
Total
31
Raised
0
Lowered
3
Avg PT
$5.63
H / L
$8 / $4
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Wedbush | Reiterated | Outperform | 2026-08-14 | — | — |
Piper Sandler | Reiterated | Overweight | 2026-08-14 | $8.00 | +234.00% |
Wells Fargo | Reiterated | Equal Weight | 2026-08-14 | $3.50 | +46.10% |
HC Wainwright & Co. | Reiterated | Buy | 2026-06-08 | — | — |
Needham | Reiterated | Hold | 2025-10-27 | — | — |
Barclays | Reiterated | Overweight | 2025-05-14 | — | — |
Baird | Reiterated | Neutral | 2025-05-14 | — | — |
Stifel | Reiterated | Hold | 2025-03-06 | — | — |
Canaccord Genuity | Reiterated | Buy | 2024-05-10 | $9.00 | +275.80% |
BMO Capital | Reiterated | Market Perform | 2024-05-10 | $5.00 | +108.80% |
B of A Securities | Reiterated | Underperform | 2024-03-28 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2024-02-27 | $8.00 | +234.00% |
Oppenheimer | Reiterated | Perform | 2024-02-27 | $135.00 | +5536.70% |
Mizuho | Reiterated | Buy | 2023-11-20 | — | — |
Cantor Fitzgerald | Reiterated | Neutral | 2023-09-07 | — | — |
Truist Securities | Reiterated | Hold | 2023-08-16 | — | — |
EF Hutton | Reiterated | Buy | 2023-08-09 | — | — |
Citigroup | Reiterated | Buy | 2023-03-02 | $87.00 | +3532.60% |
Goldman Sachs | Reiterated | Sell | 2023-01-09 | $4.00 | +67.00% |
Cowen & Co. | Downgraded | Outperform → Market Perform | 2023-01-06 | — | — |
SVB Leerink | Reiterated | Outperform | 2023-01-06 | — | — |
Guggenheim | Downgraded | Buy → Neutral | 2023-01-03 | — | — |
SunTrust Robinson Humphrey | Reiterated | Buy | 2019-11-12 | — | — |
Piper Jaffray | Reiterated | Overweight | 2019-09-16 | — | — |
BTIG | Reiterated | Buy | 2019-08-09 | — | — |
Roth Capital | Reiterated | Neutral | 2019-06-07 | $60.00 | +2405.20% |
Jefferies | Reiterated | Buy | 2018-11-05 | $4.00 | +67.00% |
H.C. Wainwright | Downgraded | Buy → Neutral | 2018-03-06 | $7.00 | +192.30% |
PiperJaffray | Reiterated | Overweight | 2017-12-18 | — | — |
Raymond James | Reiterated | Outperform | 2015-10-06 | — | — |
Leerink Swann | Reiterated | Outperform | 2015-06-01 | — | — |
Institution
Wedbush
Reiterated · Outperform · 2026-08-14
—
—
Piper Sandler
Reiterated · Overweight · 2026-08-14
$8.00
+234.00%
Wells Fargo
Reiterated · Equal Weight · 2026-08-14
$3.50
+46.10%
HC Wainwright & Co.
Reiterated · Buy · 2026-06-08
—
—
Needham
Reiterated · Hold · 2025-10-27
—
—
Barclays
Reiterated · Overweight · 2025-05-14
—
—
Baird
Reiterated · Neutral · 2025-05-14
—
—
Stifel
Reiterated · Hold · 2025-03-06
—
—
Canaccord Genuity
Reiterated · Buy · 2024-05-10
$9.00
+275.80%
BMO Capital
Reiterated · Market Perform · 2024-05-10
$5.00
+108.80%
B of A Securities
Reiterated · Underperform · 2024-03-28
—
—
Morgan Stanley
Reiterated · Equal Weight · 2024-02-27
$8.00
+234.00%
Oppenheimer
Reiterated · Perform · 2024-02-27
$135.00
+5536.70%
Mizuho
Reiterated · Buy · 2023-11-20
—
—
Cantor Fitzgerald
Reiterated · Neutral · 2023-09-07
—
—
Truist Securities
Reiterated · Hold · 2023-08-16
—
—
EF Hutton
Reiterated · Buy · 2023-08-09
—
—
Citigroup
Reiterated · Buy · 2023-03-02
$87.00
+3532.60%
Goldman Sachs
Reiterated · Sell · 2023-01-09
$4.00
+67.00%
Cowen & Co.
Downgraded · Outperform → Market Perform · 2023-01-06
—
—
SVB Leerink
Reiterated · Outperform · 2023-01-06
—
—
Guggenheim
Downgraded · Buy → Neutral · 2023-01-03
—
—
SunTrust Robinson Humphrey
Reiterated · Buy · 2019-11-12
—
—
Piper Jaffray
Reiterated · Overweight · 2019-09-16
—
—
BTIG
Reiterated · Buy · 2019-08-09
—
—
Roth Capital
Reiterated · Neutral · 2019-06-07
$60.00
+2405.20%
Jefferies
Reiterated · Buy · 2018-11-05
$4.00
+67.00%
H.C. Wainwright
Downgraded · Buy → Neutral · 2018-03-06
$7.00
+192.30%
PiperJaffray
Reiterated · Overweight · 2017-12-18
—
—
Raymond James
Reiterated · Outperform · 2015-10-06
—
—
Leerink Swann
Reiterated · Outperform · 2015-06-01
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space